NCT02998983 2023-09-11
Racotumomab in Patients With High-risk Neuroblastoma
Laboratorio Elea Phoenix S.A.
Phase 2 Completed
Clinical Trials
3 trialsNCT01598454 2015-07-29
Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides
Laboratorio Elea Phoenix S.A.
Phase 1 Completed
NCT01240447 2014-07-10
Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients
Laboratorio Elea Phoenix S.A.
Phase 2 Completed